↓ Skip to main content

Trastuzumab containing regimens for early breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news
13 news outlets
blogs
2 blogs
policy
1 policy source
twitter
56 tweeters
patent
1 patent
facebook
3 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user

Citations

dimensions_citation
401 Dimensions

Readers on

mendeley
346 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Trastuzumab containing regimens for early breast cancer
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd006243.pub2
Pubmed ID
Authors

Lorenzo Moja, Ludovica Tagliabue, Sara Balduzzi, Elena Parmelli, Vanna Pistotti, Valentina Guarneri, Roberto D'Amico

Abstract

Approximately one-fifth of women who develop early breast cancer have HER2-positive tumours, which if untreated, have a worse prognosis than HER2-negative tumours. Trastuzumab is a selective treatment targeting the HER2 pathway. Although the results on efficacy seem to support its use, there are potential cardiac toxicities which need to be considered, especially for women at lower risk of recurrence, or those at increased cardiovascular risk.

Twitter Demographics

The data shown below were collected from the profiles of 56 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 346 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 4 1%
Canada 4 1%
Korea, Republic of 2 <1%
United States 2 <1%
Austria 1 <1%
United Kingdom 1 <1%
Chile 1 <1%
Greece 1 <1%
Brazil 1 <1%
Other 0 0%
Unknown 329 95%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 44 13%
Researcher 44 13%
Student > Master 43 12%
Student > Ph. D. Student 42 12%
Student > Postgraduate 34 10%
Other 77 22%
Unknown 62 18%
Readers by discipline Count As %
Medicine and Dentistry 160 46%
Agricultural and Biological Sciences 23 7%
Biochemistry, Genetics and Molecular Biology 18 5%
Nursing and Health Professions 14 4%
Pharmacology, Toxicology and Pharmaceutical Science 11 3%
Other 40 12%
Unknown 80 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 160. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2020.
All research outputs
#140,643
of 17,469,628 outputs
Outputs from Cochrane database of systematic reviews
#271
of 11,697 outputs
Outputs of similar age
#634
of 132,504 outputs
Outputs of similar age from Cochrane database of systematic reviews
#1
of 96 outputs
Altmetric has tracked 17,469,628 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,697 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.2. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 132,504 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.